Rapid Detection of Vancomycin-Intermediate Staphylococcus aureus by Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry

Journal of Clinical Microbiology
Cheryl A MatherSusan M Butler-Wu

Abstract

Vancomycin is the standard of care for the treatment of invasive methicillin-resistantStaphylococcus aureus(MRSA) infections. Infections with vancomycin-nonsusceptible MRSA, including vancomycin-intermediateS. aureus(VISA) and heterogeneous VISA (hVISA), are clinically challenging and are associated with poor patient outcomes. The identification of VISA in the clinical laboratory depends on standard susceptibility testing, which takes at least 24 h to complete after isolate subculture, whereas hVISA is not routinely detected in clinical labs. We therefore sought to determine whether VISA and hVISA can be differentiated from vancomycin-susceptibleS. aureus(VSSA) using the spectra produced by matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS). Strains of MRSA were characterized for vancomycin susceptibility phenotype by broth microdilution and modified population analysis. We tested 21 VISA, 21 hVISA, and 38 VSSA isolates by MALDI-TOF MS. Susceptibility phenotypes were separated by using a support vector machine (SVM) machine learning algorithm. The resulting model was validated by leave-one-out cross validation. Models were developed and validated by using spectral profiles generated unde...Continue Reading

References

Oct 19, 1999·Journal of Clinical Microbiology·B ShopsinB N Kreiswirth
May 3, 2002·Analytical Chemistry·Volker EgelhoferEckhard Nordhoff
Jan 22, 2004·Bioinformatics·Emmanuel ParadisKorbinian Strimmer
Mar 29, 2005·Journal of the American Society for Mass Spectrometry·Sharon C WunschelEdward White
Jul 29, 2005·Antimicrobial Agents and Chemotherapy·Longzhu CuiKeiichi Hiramatsu
Apr 5, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Fred C Tenover, Robert C Moellering
Sep 12, 2007·Bioinformatics·M A LarkinD G Higgins
Apr 25, 2009·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Christoph K Naber
Apr 24, 2009·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·R K C FongA Kurup
May 28, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Georg Martin FiedlerJoachim Thiery
Nov 17, 2010·Antimicrobial Agents and Chemotherapy·Sebastiaan J van Hal, David L Paterson
Jan 11, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Catherine LiuHenry F Chambers
Jul 17, 2012·Bioinformatics·Sebastian Gibb, Korbinian Strimmer
Jun 26, 2013·Antimicrobial Agents and Chemotherapy·Anthony M CasapaoMichael J Rybak
Aug 13, 2013·Clinics in Laboratory Medicine·Tanis C Dingle, Susan M Butler-Wu
Dec 24, 2013·Journal of Bacteriology·Lavanya RishishwarI King Jordan
May 20, 2015·International Journal of Antimicrobial Agents·Doo Ryeon ChungJae-Hoon Song

❮ Previous
Next ❯

Citations

Apr 15, 2016·Expert Review of Anti-infective Therapy·Jan-Willem H DikAlexander W Friedrich
Oct 30, 2016·Expert Review of Molecular Diagnostics·Teresa CimminoJean-Marc Rolain
Sep 16, 2017·Current Opinion in Infectious Diseases·Nenad MacesicNicholas P Tatonetti
Mar 3, 2020·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Piyush BaindaraSanti M Mandal
Jul 14, 2020·Bioinformatics·Caroline WeisKarsten Borgwardt
Sep 8, 2016·Expert Review of Anti-infective Therapy·Emi Minejima, Annie Wong-Beringer
Dec 12, 2018·BioMed Research International·Zichuan FanYalan Dai
Sep 29, 2018·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·Ignacio TorresDavid Navarro
Jan 31, 2019·Euro Surveillance : Bulletin Européen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin·Belén Rodríguez-SánchezGilbert Greub
Oct 28, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Michał ZłochBogusław Buszewski
Feb 18, 2020·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·N Peiffer-SmadjaE Ruppé

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.